225 related articles for article (PubMed ID: 20593060)
21. Advances in endoscopic diagnosis and treatment of Barrett's esophagus.
Gaddam S; Sharma P
J Dig Dis; 2010 Dec; 11(6):323-33. PubMed ID: 21091894
[TBL] [Abstract][Full Text] [Related]
22. [Barrett's esophageal adenocarcinoma].
Nakamura T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
[TBL] [Abstract][Full Text] [Related]
23. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
25. Management of Barrett's esophagus with dysplasia.
Hagen JA
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):285-9. PubMed ID: 9263347
[TBL] [Abstract][Full Text] [Related]
26. Management of Barrett's esophagus free of dysplasia.
DeMeester SR
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
28. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
29. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
Wolfsen HC
Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
[TBL] [Abstract][Full Text] [Related]
30. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
31. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
32. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
33. Barrett's esophagus and esophageal cancer.
Streitz JM
Chest Surg Clin N Am; 1994 May; 4(2):227-40. PubMed ID: 8049993
[TBL] [Abstract][Full Text] [Related]
34. State of the art in the endoscopic imaging and ablation of Barrett's esophagus.
Panossian AM; Raimondo M; Wolfsen HC
Dig Liver Dis; 2011 May; 43(5):365-73. PubMed ID: 21330224
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and therapy of early neoplasia in Barrett's esophagus].
Pech O; May A; Gossner L; Rabenstein T; Ell C
Verh Dtsch Ges Pathol; 2003; 87():137-41. PubMed ID: 16888905
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
[TBL] [Abstract][Full Text] [Related]
37. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
38. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
39. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
40. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]